Infants aged 6 to 12 weeks of age with confirmed HIV infection and a CD4 percentage greater than or equal to 25% were randomized to deferred ART according to South African guidelines [8] (the deferred-therapy group) or immediate ART until 1 or 2 years of age (the early-therapy groups), followed by treatment interruption. Here, CD4 is linked to HIV infectious disease.